Schedule 13G ownership disclosure

iRadimed Corp

Common · CUSIP: 46266A109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nine Ten Capital Management

    Shares: 905,926 · Class: 7.1%

  • Nine Ten Partners LP

    Shares: 905,926 · Class: 7.1%

  • Russell Mollen

    Shares: 905,926 · Class: 7.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001420506-25-000363
Form type
SCHEDULE 13G
Filer
IRADIMED CORP
CIK
CIK 1325618
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub